NABL Certified Labs

Book Rheumatoid Factor Test

35+ Regional Processing Labs
4500+ Serviceable Pincodes across India
75000+ Samples Processed Daily

Test Price

₹666

Book Now
Free Home Collection Reports In 24 - 48 Hours

Quick Rheumatoid Factor Test Overview

Also Known As RF Test, RA Factor Test, Rheumatoid Arthritis Factor
Sample Type Blood (serum)
Fasting Required No
Report Delivery Within 24 hours
Age Group All adults
Gender All; predominantly women aged 30 to 60 years
Test Type Immunoturbidimetric or nephelometric assay
Units IU/mL (International Units per millilitre)
1

The Rheumatoid Factor test is a blood test that measures the level of rheumatoid factor, an autoantibody produced by the immune system that mistakenly targets the body's own immunoglobulin G antibodies. RF is most strongly associated with rheumatoid arthritis, a chronic autoimmune inflammatory joint disease, but is also found in several other autoimmune conditions, chronic infections, and in a small proportion of healthy individuals. The test is one of the oldest and most widely used serological markers in rheumatology and remains a standard component of the diagnostic workup for suspected inflammatory joint disease. Rheumatoid arthritis affects an estimated 0.5 to 1% of the Indian population and is one of the most common autoimmune diseases, predominantly affecting women between 30 and 60 years of age. It causes progressive and potentially disabling joint destruction if not diagnosed and treated early. In India, delayed diagnosis remains a significant problem as early rheumatoid arthritis is frequently misattributed to general joint pain, vitamin deficiencies, or age-related changes. The RF test, interpreted alongside anti-CCP antibodies, CRP, ESR, and clinical examination, is a critical component of early diagnosis that enables timely initiation of disease-modifying therapy to prevent irreversible joint damage. The test involves a simple blood draw completed in under five minutes.
2

Doctors prescribe a Rheumatoid Factor test in the following situations: Diagnosing rheumatoid arthritis in patients presenting with symmetrical joint pain and swelling affecting the small joints of the hands and feet, morning stiffness lasting more than one hour, and fatigue where RF positivity alongside anti-CCP supports the diagnosis and guides early treatment decisions. Evaluating undifferentiated inflammatory arthritis in patients with joint inflammation that does not yet meet full diagnostic criteria for a specific condition, where RF helps classify the arthritis and predict the likelihood of progression to established rheumatoid arthritis. Assessing disease prognosis in newly diagnosed rheumatoid arthritis where high titre RF positivity is associated with more aggressive disease, greater risk of joint erosions, extra-articular manifestations, and poorer long-term outcomes compared to seronegative disease. Investigating Sjogren's syndrome in patients with dry eyes, dry mouth, fatigue, and joint pain where RF is positive in up to 70 to 80% of cases and is part of the diagnostic workup alongside anti-SSA and anti-SSB antibodies. Evaluating other autoimmune conditions including systemic lupus erythematosus, mixed connective tissue disease, and systemic sclerosis where RF can be positive and contributes to the overall autoimmune serological profile. Investigating chronic infections including hepatitis B, hepatitis C, tuberculosis, infective endocarditis, and leprosy where RF is frequently positive as a non-specific immune response and must be distinguished from autoimmune RF positivity. Monitoring established rheumatoid arthritis patients where serial RF titres alongside CRP and ESR provide information on disease activity and response to disease-modifying antirheumatic drug therapy over time.
3

The Rheumatoid Factor test measures the concentration of rheumatoid factor antibodies in the blood, reported in international units per millilitre (IU/mL). Normal Rheumatoid Factor Range in India The standard reference range used across most Indian diagnostic laboratories is as follows. An RF level below 14 IU/mL is considered negative and within the normal range. An RF level between 14 and 60 IU/mL is considered weakly to moderately positive. An RF level above 60 IU/mL is considered strongly positive. Interpreting Rheumatoid Factor Results A negative RF does not exclude rheumatoid arthritis as approximately 20 to 30% of rheumatoid arthritis patients are seronegative, meaning they have RF-negative disease. In these cases, anti-CCP antibodies, which are more specific for rheumatoid arthritis, are particularly important and clinical diagnosis is made on the basis of joint examination, imaging, and other inflammatory markers. A weakly positive RF between 14 and 60 IU/mL requires careful interpretation as it can be seen in healthy elderly individuals, chronic infections, other autoimmune conditions, and early rheumatoid arthritis. Clinical context and repeat testing alongside anti-CCP are essential before attributing significance to a weakly positive result. A strongly positive RF above 60 IU/mL in a patient with characteristic joint symptoms is highly supportive of rheumatoid arthritis and warrants urgent rheumatological evaluation and early initiation of disease-modifying therapy to prevent joint erosions.
4

No fasting is required for the Rheumatoid Factor test. You can eat and drink normally before sample collection. Our team confirms preparation requirements at the time of booking. Inform the phlebotomist about all medications you are currently taking, particularly disease-modifying antirheumatic drugs, corticosteroids, and biological therapies, as immunosuppressive treatment can lower RF titres and must be disclosed for accurate interpretation. Inform your doctor about any recent or current infections including hepatitis B, hepatitis C, or tuberculosis as chronic infections independently elevate RF and must be excluded as the cause of a positive result before attributing it to an autoimmune condition. No dietary or lifestyle restrictions are required beyond the above. Stay normally hydrated before sample collection.
5

If you are booking through the SecondMedic platform the Rheumatoid Factor test price starts at approximately Rs. 666. The exact price will be confirmed at the time of booking through SecondMedic. If your doctor has prescribed multiple tests alongside RF, SecondMedic health packages include RF as part of a broader autoimmune or rheumatology panel at a significantly lower combined price.
6

SecondMedic provides home sample collection for Rheumatoid Factor test across all major areas in India. You do not need to visit a lab or collection centre. A certified and trained phlebotomist comes to your home or workplace at your chosen time, collects the sample using sterile single-use equipment, and ensures it is transported to the NABL-accredited lab within the required time window for accurate processing. Please note that SecondMedic provides free home sample collection on all tests priced above Rs. 300. Our team will check your pincode and confirm if your address falls under our free sample collection eligibility criteria, which depends upon the lab location and phlebotomist availability. Home collection is available between 7 AM and 10 PM, seven days a week, including Sundays and public holidays. Enter your pincode on the booking page or call our helpline to confirm availability at your address.

Our Presence In India

People Also Ask

Rheumatoid factor is an autoantibody, typically of the IgM class, that targets the body's own IgG antibodies as if they were foreign. Its production reflects a breakdown in immune self-tolerance. While closely associated with rheumatoid arthritis, RF can also be produced in response to chronic infections, other autoimmune diseases, and even in a small proportion of healthy older adults.

Anti-CCP antibodies target citrullinated proteins and are significantly more specific for rheumatoid arthritis than RF, which can be positive in many non-rheumatoid conditions. Combining both tests improves diagnostic accuracy: a patient who is positive for both RF and anti-CCP has a very high likelihood of rheumatoid arthritis, while anti-CCP can confirm the diagnosis in the 20 to 30 percent of patients who are RF-negative.

Seronegative rheumatoid arthritis refers to disease where both RF and anti-CCP are negative despite the presence of characteristic clinical features including symmetrical joint inflammation and morning stiffness. Approximately 20 to 30 percent of rheumatoid arthritis patients are seronegative. Diagnosis in these cases relies on clinical examination, imaging evidence of joint inflammation, and elevated inflammatory markers such as CRP and ESR.

High RF titres at diagnosis are consistently associated with more aggressive joint inflammation, faster progression to joint erosion and structural damage, a higher likelihood of extra-articular disease manifestations including lung involvement and vasculitis, and reduced response to conventional disease-modifying therapy. These patients benefit most from early initiation of aggressive treatment including biological agents.

Hepatitis C is one of the most common causes of elevated RF in India and must always be excluded before attributing a positive RF to an autoimmune cause. Tuberculosis, hepatitis B, infective endocarditis, and leprosy can also independently elevate RF through chronic immune system stimulation. Appropriate infection screening is therefore essential alongside autoimmune evaluation in any patient with a positive RF result.

Sjogren's syndrome is an autoimmune condition primarily causing dry eyes and dry mouth due to immune attack on salivary and lacrimal glands. RF is positive in 70 to 80 percent of Sjogren's patients and is part of the diagnostic workup alongside anti-SSA and anti-SSB antibodies, Schirmer's test for tear production, and minor salivary gland biopsy in clinically suspected cases.

In some patients, effective treatment with disease-modifying antirheumatic drugs or biological therapies can lower RF titres over time, though complete seroreversion is uncommon. A falling RF titre during treatment may reflect disease suppression but is not used as the primary measure of treatment response. Clinical joint examination, CRP, ESR, and imaging remain the main tools for monitoring treatment effectiveness.

Low-titre RF positivity occurs in 5 to 10 percent of healthy individuals over 65 years of age without any autoimmune disease, a phenomenon attributed to age-related changes in immune regulation. An isolated weakly positive RF in an asymptomatic elderly person without joint symptoms, dry eyes, or other clinical features does not warrant treatment and should not be over-interpreted without corroborating clinical evidence.

Patients with strongly positive RF are at significantly higher risk of developing complications beyond the joints. These include rheumatoid lung disease causing interstitial fibrosis, rheumatoid vasculitis affecting small blood vessels, pericarditis, peripheral neuropathy, and rheumatoid nodules beneath the skin. Awareness of these systemic manifestations is important in the long-term follow-up of high-titre seropositive patients.

Content Reviewed By

Reviewer
Reviewed by:

Dr. Kovid Pandey

MBBS, General Physician

Last Reviewed: 10th Mar 2026

References

1
Aletaha D et al.: Rheumatoid Arthritis Classification Criteria: An ACR/EULAR Collaborative Initiative, Arthritis and Rheumatism, 2010 — onlinelibrary.wiley.com
2
European League Against Rheumatism: EULAR Recommendations for the Management of Rheumatoid Arthritis, Annals of the Rheumatic Diseases, 2022 — ard.bmj.com
3
Indian Rheumatology Association: Consensus Recommendations for Management of Rheumatoid Arthritis in India, Indian Journal of Rheumatology, 2021 — www.indianjrheumatol.com
4
Nishimura K et al.: Meta-Analysis: Diagnostic Accuracy of Anti-CCP Antibodies and RF for Rheumatoid Arthritis, Annals of Internal Medicine, 2007 — www.acpjournals.org
5
Nell VPK et al.: Autoantibody Profiling as Early Diagnostic and Prognostic Tool for Rheumatoid Arthritis, Annals of the Rheumatic Diseases, 2005 — ard.bmj.com

Download Our App & Get Consultation from anywhere.

App Download